This company has shut down. Trace Genomics is no longer operating — its last tracked round was a Series B in 2024.
Explore the Startup GraveyardTrace Genomics provides genetic insights into soil, helping farmers optimize their agricultural practices for better crop yield.
Trace Genomics has raised $10.5M in total funding. The most recent round was Series B. The last funding was announced in February 2024.
Trace Genomics's investors include S2G Investments, Refactor, SVG Ventures, AgFunder, Viking Global Investors.
Trace Genomics is headquartered in Burlingame, United States.
Trace Genomics provides genetic insights into soil, helping farmers optimize their agricultural practices for better crop yield.
Trace Genomics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trace Genomics — Funding & Investors." VCBacked, February 20, 2024, https://www.vcbacked.co/company/trace-genomics. Accessed August 14, 2026.
VCBacked. (2024). Trace Genomics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/trace-genomics
{{cite web |title=Trace Genomics — Funding & Investors |url=https://www.vcbacked.co/company/trace-genomics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated